{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/647732f050150f001123b38e/67613df4d9cd65ec1e43c3ee?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Gentamicin - med Jan Kristian Damås","description":"<p>Vi har vært på konferanse og intervjuet professor Jan Kristian Damås om gentamicin – et effektivt og i skandinavisk sammenheng hyppig brukt antibiotikum - men internasjonalt også mye debattert legemiddel.</p><p><br></p><p><strong>Referanser:&nbsp;</strong></p><ol><li>Ritchie ND, Irvine SC, Helps A, Robb F, Jones BL, Seaton RA.&nbsp;<strong>Restrictive antibiotic stewardship associated with reduced hospital mortality in gram-negative infection.</strong>&nbsp;Qjm. 2017;110(3):155-61.</li><li>McDermott JH, Mahaveer A, James RA, Booth N, Turner M, Harvey KE, et al.&nbsp;<strong>Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care</strong>. JAMA Pediatrics. 2022;176(5):486-92.</li><li>Grønmo M, Møller-Stray J, Akselsen PE, Lindemann PC, Fostervold A, Vestby Knudsen C, Knudsen PK, Lindbæk M, Tonby K, Sundsfjord A.&nbsp;<strong>Gentamicin bør fortsatt inngå i empirisk sepsisregime hos voksne.</strong>&nbsp;Tidsskr Nor Legeforen. 2024.</li><li>Vidal L, Gafter-Gvili A, Borok S, Fraser A, Leibovici L, Paul M. <strong>Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials.</strong> J Antimicrob Chemother. 2007 Aug;60(2):247-57.</li></ol>","author_name":"Helse Bergen"}